The Mogam Science Scholarship Foundation was created with the goal of encouraging and supporting young Korean scientists with scholarships and research grants to enable them to contribute to scientific and technological advancements in and outside Korea.
※ Visit the Mogam Science Scholarship Foundation website for more information.
The late founding chairman of GC Pharma, Huh Young-sup, founded the KHF in line with the company’s commitment to producing hemophilia treatments, beginning in 1974, under its mission of serving Korean society, local communities, and fellow Koreans. The foundation provides a wide range of support to facilitate systematic and efficient treatment and rehabilitation for persons struggling with hereditary hemophilia.
GC Pharma, which began producing plasma derivatives in the early 1970s, turned its attention to production of its own hemophilia treatment
(an anti-hemophilic factor or AHF) in 1974. The company’s determination to help hemophilic patients culminated with creation of the KHF two decades later.
GC Pharma consulted hemophilia organizations in the United States and other developed countries, and sent a delegation to a hemophilia treatment center in Bonn, Germany, to survey its facilities and management. The company then teamed up with the mothers of hemophilic patients and the Hemophilic Patients Rehabilitation Association to launch the KHF.
※ Visit the KHF website for more information